rss
Br J Ophthalmol 2005;89:632-638 doi:10.1136/bjo.2003.040675
  • Laboratory science - Extended reports

Corneal graft rejection occurs despite Fas ligand expression and apoptosis of infiltrating cells

  1. K A Williams1,
  2. S D Standfield1,
  3. J R Smith2,
  4. D J Coster1
  1. 1Department of Ophthalmology, Flinders University of South Australia, Adelaide, Australia
  2. 2Casey Eye Institute, Oregon Health and Science University, Portland, OR, USA
  1. Correspondence to: Dr Keryn A Williams Department of Ophthalmology, Flinders Medical Centre, Bedford Park, SA 5042, Australia; keryn.williamsflinders.edu.au
  • Accepted 17 September 2004

Abstract

Background/aims: Constitutive expression of Fas ligand (CD95L) protects the eye against cell mediated immune responses by inducing apoptosis in infiltrating Fas bearing T cells. This study was designed to examine Fas ligand expression on acutely rejecting rat corneal grafts and to investigate the kinetics of induction of apoptosis in infiltrating leucocytes.

Methods: Orthotopic penetrating corneal transplantation was performed between genetically disparate inbred rats. Fas ligand expression and the phenotype of infiltrating leucocytes were examined by immunohistochemistry. Apoptotic nuclei were visualised in sections of normal rat cornea, rejecting allografts, and time matched isografts by terminal deoxynucleotidyl transferase mediated dUTP biotin nick end labelling (TUNEL) and quantified by video image analysis. Staining with Hoechst dye 33258 was used to confirm the presence of apoptotic nuclei.

Results: Fas ligand was expressed on corneal endothelial and epithelial cells during acute corneal graft rejection. At all time points examined, including as early as the fifth postoperative day, the cells infiltrating both corneal isografts and allografts were TUNEL positive. By the 15th postoperative day, over 90% of all nuclei, many of which were T cells, were apoptotic.

Conclusion: Expression of Fas ligand is not downregulated on the cornea during allograft rejection and infiltrating leucocytes in both isografts and allografts die rapidly in situ. Despite the death of the cells believed to be responsible for rejection, isografts survive indefinitely whereas allografts are irreparably damaged.

Footnotes

  • This work was supported by grants from National Health and Medical Research Council of Australia and the Ophthalmic Research Institute of Australia. Dr Smith is supported by a Career Development Award from Research to Prevent Blindness. There are no commercial or proprietary interests related to this manuscript.

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.